CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company
NextCure, Inc.
Sign in to watch- Ticker
- NXTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475231247
- Phone
- 240-399-4900
- Business address
- 2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
- Open-market buys, last 90 days
- $77,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$77,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-31 | Langermann Sol Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +117,375 | 117,375 | ||
| 2024-01-31 | Kundu Sourav Sr VP, Dev. & Mfg. | Grant or award · Employee Stock Option (Right to Buy) | +66,125 | 66,125 | ||
| 2024-01-31 | Cobourn Steven P. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +117,375 | 117,375 | ||
| 2023-06-22 | Nicholson Garry A Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2023-06-22 | KABAKOFF DAVID S Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2023-06-22 | Khuong Chau Quang Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2023-06-22 | Houston John G Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2023-06-22 | Feigal Ellen Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2023-06-22 | Jones Elaine V Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2023-06-22 | Webster Stephen W Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2023-06-22 | Borgman Anne Elizabeth Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2023-02-28 | Mayer Timothy Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2023-02-28 | Kundu Sourav Sr VP, Dev. & Mfg. | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2023-02-28 | Myint Han Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2023-02-28 | Shaw Kevin G. Sr VP, Legal Affairs | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2023-02-28 | Langermann Sol Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2023-02-28 | Richman Michael President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +309,000 | 309,000 | ||
| 2023-02-28 | Cobourn Steven P. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2022-06-23 | Feigal Ellen Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2022-06-23 | Borgman Anne Elizabeth Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 |
Page 4 of 10 · 197 trades